Purifarma

What Purifarma does

Purifarma Distribuidora Química e Farmacêutica is a privately held Brazilian pharmaceutical input distributor founded in 1988 (1989 per some sources) and headquartered in Anápolis, Goiás. The company specializes in importing and distributing pharmaceutical, chemical, and cosmetic raw materials, with a portfolio of more than 300 SKUs including active pharmaceutical ingredients, excipients, capsules, vitamins, minerals, amino acids, probiotics, herbal extracts, and cosmetic actives sourced from global suppliers. Its primary customer segment is the Brazilian magistral (compounding) pharmacy market, with additional reach into pharmaceutical, cosmetic, food supplement, and veterinary manufacturing industries.

The company operates a multi-branch distribution platform with three Brazilian locations: the Anápolis matrix housing the main distribution center and quality control laboratories, a commercial branch in São Paulo serving the metropolitan market, and an operations branch in São Bernardo do Campo (Lepuge operations). Quality infrastructure is a stated differentiator, including an in-house laboratory with ICP-OES spectrometry for metallic impurity analysis and physico-chemical/microbiological testing aligned to Brazilian Pharmacopoeia, USP, EP, and BP compendia. Beyond generic distribution, Purifarma has developed a portfolio of registered proprietary brands including Bioferrin (lactoferrin viral inhibitor), Inaclear (DKK-1-based skin brightening), BHB (beta-hydroxybutyrate), Neoimuno (MAMP probiotic formulations with licensed GanedenBC30 strains), EXTRADERM (cosmetic bases), Probioage, Tinofolin, and Purivet for veterinary applications.

The business model is B2B distribution with sales-led go-to-market, combining a field sales team, dedicated pharmacy and industrial sales departments, toll-free 0800 phone support, WhatsApp Business contact, and an online catalog at magistral.purifarma.com.br. Pricing is not publicly disclosed and is negotiated based on volume and relationship. The company holds 100% national capital, with no disclosed funding rounds, parent company, or institutional investors, and partners with Consulfarma (an associated company) for digital presence and industry events such as the Consulfarma Congress. Regulatory compliance spans ANVISA (including RDC 204/2006 Good Distribution Practices), MAPA for veterinary inputs, and multiple municipal certifications, which collectively form a meaningful compliance moat in the Brazilian specialty distribution market.

Name

Purifarma

Legal name

Purifarma Distribuidora Química e Farmacêutica

Website

https://purifarma.com.br

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

101–250 employees

Short description

Purifarma is a privately held Brazilian distributor (founded 1988, Anápolis-based) supplying over 300 pharmaceutical, cosmetic, food, and veterinary raw materials to compounding pharmacies and industrial manufacturers across Brazil, with proprietary branded actives and in-house ICP-OES quality control.

Ownership category

akta.pro rank

Product category

Pharmaceutical Input Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Farm Product Raw Materials (5150)

akta.pro primary industry

Fortification Ingredients (Vitamins, Minerals, Nutrient Premixes) (CRADAOAM)

Keywords

• Pharmaceutical input distribution
• Active pharmaceutical ingredients
• Magistral pharmacy supplies
• Cosmetic raw materials
• Veterinary pharmaceutical inputs

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Input Distribution: Purifarma generates revenue through distribution and sale of pharmaceutical, chemical, and cosmetic inputs to magistral pharmacies, pharmaceutical, cosmetic, food, and veterinary industries across Brazil. Products include active pharmaceutical ingredients, capsules, raw materials, vitamins, minerals, amino acids, probiotics, and cosmetic actives acquired from global suppliers.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Purifarma distributes pharmaceutical, chemical, and cosmetic raw materials (active ingredients, excipients, vitamins, minerals, amino acids, probiotics, and cosmetic actives) to compounding pharmacies, pharmaceutical manufacturers, cosmetic companies, food supplement producers, and veterinary compounders across Brazil. The company also markets its own branded actives (Inaclear, BHB, Bioferrin) and operates a quality control laboratory supporting regulatory compliance for ANVISA and MAPA requirements.

Product overview

Purifarma is a Brazilian pharmaceutical ingredients distributor offering a comprehensive portfolio of over 300 pharmaceutical, chemical, and cosmetic raw materials to the compounding pharmacy (magistral) market. The company operates as a single unified distribution platform offering: (1) proprietary branded actives including INACLEAR (skin brightening), BHB (metabolic supplement), and Bioferrin (lactoferrin immunomodulator); (2) EXTRADERM cosmetic base formulations; (3) NEOIMUNO branded probiotic/MAMP products; and (4) a broad catalog of generic pharmaceutical ingredients spanning vitamins, minerals, amino acids, herbal extracts, and excipients. All products are sourced from global suppliers and distributed throughout Brazil's compounding pharmacy sector.

Differentiator

Problem solved

Functional benefit

Products and services

• Inaclear Biomimetic active ingredient for innovative skin brightening that works via inhibition of melanogenesis through the DKK-1 pathway, supplied to cosmetic formulators and compounding pharmacies.
• BHB - Beta Hydroxybutyrate Exogenous BHB ketone body supplement that acts as a metabolic substrate for ATP production in mitochondria, used as a pre-workout supplement to support physical and mental performance and promote satiety via ghrelin reduction.
• Bioferrin (Lactoferrin) Registered trademark active ingredient based on lactoferrin that works as a viral inhibitor with iron ion transport, immunomodulatory, antimicrobial, cell proliferation, anti-inflammatory, and anti-viral functions for compounding pharmacies.
• EXTRADERM Product Line Cosmetic base formulations for compounding pharmacies, including cold cream, anionic and non-ionic creams, water/silicone emulsions, carbopol and natrosol gels, lotions, shampoos, and liquid soaps.
• NEOIMUNO MAMP Probiotic Line MAMP (Microbe-Associated Molecular Patterns) probiotic product line featuring multiple Lactobacillus and Bifidobacterium strains (Bifidobacterium lactis GB, Lactobacillus acidophilus GB, L. bulgaricus, L. casei, L. gasseri, L. paracasei, L. plantarum, L. rhamnosus, Streptococcus thermophilus GB).
• Pharmaceutical Ingredients Portfolio Over 300 pharmaceutical, chemical, and cosmetic raw materials distributed to compounding pharmacies, including amino acids, vitamins, minerals, herbal extracts, cosmetic actives, and pharmaceutical excipients sourced from global suppliers.
• Purivet Veterinary Product Catalog Registered trademark catalog of pharmaceutical inputs tailored for veterinary compounding pharmacies and MAPA-registered establishments.

Quantifiable outcome

• One of the largest pharmaceutical input distributors in Latin America
• +1 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• ConsulfarmacoreStrategic or Co-development PartnerConsulfarma is an associated company providing support services to Purifarma. Website development and digital presence maintained by Consulfarma. Partnership in industry events including Consulfarma Congress where Purifarma showcases new products and innovations to the pharmaceutical compounding market.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Fagron: Global market leader in pharmaceutical compounding raw materials, distributing APIs, excipients, and bases to compounding pharmacies worldwide. Closest direct peer given Purifarma's identical magistral-pharmacy go-to-market model and ingredient portfolio.
• Letco Medical (Letco Companies): US-based specialty distributor of APIs, excipients, equipment, and bases serving independent compounding pharmacies. Highly comparable given its compounding-focused B2B distribution model and similar product breadth.
• Spectrum Chemical: US-based distributor and manufacturer of over 1,200 fine chemicals, APIs, and excipients to pharmaceutical, food, and cosmetic customers. Directly comparable ingredient breadth and regulated B2B customer base.
• ICC Chemical: Specialty chemicals and ingredients distributor serving pharmaceutical, cosmetic, and food manufacturers across emerging markets including Latin America. Comparable mid-tier distribution model with multi-vertical reach.

Broad incumbents

• IMCD Group: Global specialty chemicals and ingredients distributor serving pharmaceutical, personal care, food, and industrial markets with technical sales support. Larger-scale incumbent with overlapping pharma/cosmetic ingredient distribution.
• Brenntag: World's largest chemical distribution company with pharma, personal care, food, and animal nutrition verticals. Relevant incumbent because its pharma and life-sciences distribution arm competes for the same industrial and compounding customers.
• Univar Solutions: Global chemical and ingredient distributor with strong North American and European pharmaceutical and personal care presence. Comparable as broad-line distribution incumbent serving overlapping industrial end markets.
• Azelis: Global specialty ingredients distributor focused on personal care, pharma, food, and home care with strong technical/sales infrastructure. Broader incumbent with overlapping ingredients portfolio in cosmetic and pharma verticals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Purifarma
• LinkedInlinkedin.com/company/purifarma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Purifarma